窩客幫-分身行銷廣告平台

Glac Biotech, a health food subsidiary of the Shengde Pharmaceutical Group, has made remarkable achievements in the development of probiotics and prebiotic products. Its business covers five continents and its innovative technology, PRONEX®, has significantly improved the health of probiotic strains. Combined with solid clinical trial results, Feng Hua's products are highly recognized by brands in the UK, US, Australia, Korea, and Southeast Asia, opening up a new chapter in the international probiotic raw materials market.

Although Glac's international expansion has not been smooth sailing, the company has overcome early challenges and embarked on a strategic positioning approach to benchmark international giants. Through comprehensive scientific research and development, collaboration with equipment suppliers from Northern Europe, and the acquisition of internationally recognized certified factories, Feng Hua has become the only biotech company in Asia that can compete with international probiotic giants. With its natural, scientific, and innovative products and high-quality manufacturing processes, Feng Hua has established solid partnerships in Europe, North America, Asia, Africa, and Australia, and its international reputation continues to grow each year.